Ozempic, the uber-popular injectable diabetes drug, has had to update its potential side effect warnings to include intestinal blockage.
In the suit, the woman alleges in her lawsuit that Ozempic and Moujnaro both caused her to vomit so much that she lost teeth.
"As a result of using... Ozempic and Mounjaro," the suit reads, "Plaintiff was caused to suffer from severe gastrointestinal events, which resulted in, for example, severe vomiting, stomach pain, gastrointestinal burning, being hospitalized for stomach issues on several occasions including visits to the emergency room, teeth falling out due to excessive vomiting, requiring additional medications to alleviate her excessive vomiting, and throwing up whole food hours after eating.
"For semaglutide," the Danish company continued, "the majority of GI side effects are mild to moderate in severity and of short duration." Though ileus or intestinal blockages weren't mentioned in that suit, these label updates could serve to protect Novo Nordisk and Eli Lilly, the maker of Moujnaro, from legal action — and hopefully, will be taken into account by patients when weighing whether to take the increasingly-popular injections.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA updates Ozempic label with potential blocked intestines side effect, also reported with Wegovy and MounjaroThe FDA stopped short of saying the potentially life-threatening condition was caused by the drugs, which have become popular for weight loss.
Read more »
FDA updates Ozempic label to acknowledge some users' reports of blocked intestinesThe U.S. Food and Drug Administration has updated the label of the diabetes drug Ozempic to acknowledge reports of blocked intestines in some people using the medication.
Read more »
FDA Adds Warning to Ozempic Label About Risk for Blocked IntestinesOzempic, a type 2 diabetes drug that has increasingly been used to help with weight loss, will now be labeled as having the potential to block intestines.
Read more »
Blocked Intestines Warning Added to Ozempic LabelOzempic, a Type 2 diabetes drug that has increasingly been used to help with weight loss, will now be labeled as having the potential to block intestines. The U.S. Food and Drug Administration recently made the label update for the drug made by Novo Nordisk, without directly...
Read more »
New consumer warning about websites selling drugs like Ozempic, Mounjaro used for weight lossSome websites are selling discounted versions of popular drugs like Wegovy and Ozempic.
Read more »
Ozempic label updated after reports of blocked intestinesThe Food and Drug Administration updated the label of the diabetes drug Ozempic.
Read more »